Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesClindamycin phosphate/tretinoin gel formulation in the treatment of acne vulgaris
Expert Opinion in Pharmacotherapy, 11/03/08
Abdel-Naser MB et al. - Clindamycin phosphate 1.2% together with tretinoin 0.025% as a gel (CTG) is a topical formulation of a fixed and stable combination approved by the FDA for the treatment of acne vulgaris in patients 12 years of age or older. The main indication of CTG is the management of moderate comedonal and mild-to-moderate papulopustular acne, an acne form which is present in more than 50% of acne patients. CTG can also be combined with systemic antiacne therapy, such as systemic isotretinoin, in nodulocystic acne.
| Previous Article | Next Article |
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas
Cancer, 06/01/09
A population-based clinical trial of irinotecan and carboplatin
Journal of Oncology, 06/15/09
Rifampin and Linezolid in the Treatment of Methicillin-Resistant Staphylococcus aureus Preseptal Cellulitis
Ophthalmic Plastic and Reconstructive Surgery, 06/05/09
Article Search
Sponsor